We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current DLB market cap is 7.48B. The company's latest EPS is USD 2.0994 and P/E is 37.29.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 334.92M | 375.89M | 298.37M | 290.56M | 315.57M |
Operating Income | 94.09M | 109.22M | 15.94M | -3.49M | 66.22M |
Net Income | 79.38M | 95.7M | 16.4M | 9.19M | 66.98M |
Year End September 28 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.24B | 1.16B | 1.28B | 1.25B | 1.3B |
Operating Income | 257.08M | 218.74M | 330.52M | 206.61M | 215.75M |
Net Income | 255.15M | 231.36M | 310.23M | 184.09M | 200.66M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2.75B | 2.84B | 3.01B | 2.98B | 2.94B |
Total Liabilities | 456M | 480.14M | 625.22M | 607.58M | 573.22M |
Total Equity | 2.29B | 2.36B | 2.38B | 2.37B | 2.36B |
Year End September 28 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2.82B | 2.92B | 3.11B | 2.69B | 2.98B |
Total Liabilities | 508.72M | 478.92M | 501.46M | 438.53M | 607.58M |
Total Equity | 2.31B | 2.44B | 2.6B | 2.25B | 2.37B |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 56.4M | 160.94M | 282.07M | 367.08M | 8.41M |
Investing | 28.3M | 51.89M | 73.92M | 54.21M | 633k |
Financing | -90.09M | -157.19M | -194.01M | -236.81M | -125.14M |
Year End September 28 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 327.67M | 343.85M | 447.75M | 318.58M | 367.08M |
Investing | -56.23M | 134.37M | -44.91M | -295.94M | 54.21M |
Financing | -385.28M | -207.78M | -252.52M | -610.56M | -236.81M |
Market Cap | 7.48B |
Price to Earnings Ratio | 37.29 |
Price to Sales Ratio | 5.76 |
Price to Cash Ratio | 10.04 |
Price to Book Ratio | 3.15 |
Dividend Yield | 1.46% |
Shares Outstanding | 95.58M |
Average Volume (1 week) | 282.11k |
Average Volume (1 Month) | 290.78k |
52 Week Change | -8.97% |
52 Week High | 91.015 |
52 Week Low | 75.87 |
Spread (Intraday) | 1 (1.27%) |
Company Name | Dolby Laboratories Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.dolby.com |
Industry | patent owners and lessors (6794) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions